For patients with localized kidney cancer (confined to the kidney and not yet spread), surgeons strongly prefer partial nephrectomy (PN) - an operation that removes only the tumor while leaving the rest of the kidney intact. This approach preserves kidney function better than removing the entire kidney, which is critical for long-term health and quality of life.
However, not all kidney tumors are equally straightforward to remove with partial nephrectomy. A tumor's size, location within the kidney, and relationship to critical structures like blood vessels and the urine-collecting system all affect how difficult and risky the surgery will be. Surgeons need to assess these features carefully before choosing their approach.
In the past, surgeons evaluated these factors subjectively by reviewing CT or MRI scans. To bring more consistency and objectivity to this process, researchers developed nephrometry scoring systems - standardized methods that use measurements from imaging to produce a numerical score reflecting surgical complexity.
The DAP (Diameter-Axial-Polar) nephrometry system was developed in 2012 as a simplified alternative to earlier systems. It combines three key measurements - tumor diameter, position on the kidney's central axis, and position relative to the kidney's poles - into a single score. This study tested how well the DAP score predicts surgical outcomes in an independent group of patients.
This was a retrospective study conducted at a single kidney cancer center in China, reviewing records of 285 patients who underwent partial nephrectomy between 2009 and 2013. After excluding patients without adequate imaging data or with multiple tumors in the same kidney, 237 patients were included in the final analysis.
Patients underwent surgery via four different approaches: open surgery (27%), conventional laparoscopy (39.6%), laparo-endoscopic single-site surgery (3.4%), and robotic-assisted surgery (30%). The choice of surgical technique was made by the operating surgeon based on the individual patient's circumstances.
Before surgery, each patient's CT or MRI images were reviewed by a radiologist and a urologist to assign a DAP score. The score rates three aspects of the tumor: diameter (size), axial position (where the tumor sits along the kidney's central axis), and polar position (whether it is at the top, bottom, or middle of the kidney). These three scores are added together for a total DAP sum score.
The main outcomes measured were: how long the kidney's blood supply needed to be blocked during surgery (ischemia time), and how much kidney function was lost after surgery (measured by the decline in estimated glomerular filtration rate, or eGFR). Ischemia time above 20 minutes and eGFR decline above 10% were defined as the key cutoff thresholds.
The DAP sum score showed statistically significant correlations with all major surgical outcomes tested: ischemia time, operative time, estimated blood loss, length of hospital stay, and the percentage decline in kidney function after surgery. Higher DAP scores consistently corresponded to more difficult surgeries and worse outcomes.
When it came to predicting ischemia time exceeding 20 minutes - a clinically important threshold above which kidney damage risk increases significantly - the DAP sum score was a strong independent predictor (odds ratio 1.749, p less than 0.001). This means each one-point increase in DAP score increased the odds of prolonged ischemia by about 75%.
The surgical approach also mattered. Patients undergoing conventional laparoscopy or single-site surgery had more than 5 times the odds of ischemia time exceeding 20 minutes compared to those who had open surgery. Robotic surgery, however, did not significantly differ from open surgery in this regard.
Among the three individual components of the DAP score, the diameter score and axial score performed better than the polar score. The diameter and axial components were each significantly associated with ischemia time and operative time, while the polar score was only significantly linked to blood loss and hospital stay length.
A decline in kidney filtration rate (eGFR) greater than 10% after surgery was observed in 50.7% of patients - a meaningful loss that can have long-term health implications. The DAP sum score was an independent predictor of this outcome (odds ratio 1.297, p=0.016), remaining significant even after accounting for other factors.
Other independent predictors of kidney function decline included: the Charlson Comorbidity Index (CCI) - a measure of pre-existing health conditions (odds ratio 4.730); estimated blood loss during surgery (odds ratio 2.433); and ischemia time (odds ratio 3.332). These findings highlight that kidney function loss after surgery depends on both the complexity of the tumor and how the surgery goes.
An important finding was that the DAP score and ischemia time were not fully independent of each other in predicting kidney function loss. The interaction between these two factors was statistically significant (p less than 0.001), suggesting that the DAP score's effect on kidney function partly works through its influence on how long the blood supply needs to be cut off during surgery.
In a separate analysis using only the axial and polar components of the DAP score (excluding tumor diameter), the size-adjusted score could still predict ischemia time above 20 minutes, showing that the positioning of the tumor within the kidney - independent of its size - adds meaningful information about surgical difficulty.
Several other nephrometry systems exist, including R.E.N.A.L. nephrometry, the PADUA system, and the C-index. Earlier research had shown that all of these systems could predict surgical outcomes to varying degrees. DAP was developed specifically to address limitations in these earlier systems - particularly complexity of measurement and variability between different raters.
The DAP system's main advantage is its simplified methodology. It requires fewer measurements than R.E.N.A.L. and PADUA, and its component scores are more clearly linked to anatomical features that surgeons already consider intuitively when planning an operation. This makes it faster to calculate and easier to apply in routine clinical practice.
Tumor size, which is one component of the DAP score, was also significantly associated with surgical outcomes on its own. This confirms what surgeons already know: larger tumors are generally harder to remove. However, the DAP sum score outperformed tumor size alone in predicting eGFR decline, suggesting the positional information in the score adds meaningful value beyond just size.
The results here are consistent with the original validation of the DAP system, but this study used a stricter statistical approach - including nonparametric tests and more detailed interaction analyses - providing a more rigorous confirmation in an external, independent patient population from a different country and institution.
For patients facing kidney cancer surgery, tools like the DAP score help their surgical team make better-informed decisions. Before an operation, knowing the DAP score gives the surgeon a clearer picture of how complex the procedure will be - which can guide the choice of surgical approach (open vs. laparoscopic vs. robotic) and help patients understand what to expect.
A high DAP score signals a more complex tumor location, suggesting the patient may need a longer surgery, may experience greater blood loss, and may face a higher risk of significant kidney function loss afterward. This information is valuable for counseling patients about surgical risks and setting realistic expectations about recovery.
The finding that ischemia time - how long the kidney's blood supply is blocked - plays a major role in kidney function loss after surgery is clinically important. Surgeons are already motivated to minimize ischemia time, and the DAP score can help them prioritize which cases require the most efficient surgical execution or may benefit from techniques that avoid clamping altogether.
Overall, incorporating nephrometry scoring like DAP into routine preoperative planning has the potential to improve surgical outcomes for kidney cancer patients by enabling more objective risk stratification and individualized surgical planning.
This study confirmed that the DAP nephrometry scoring system is a valid and clinically useful tool for predicting surgical outcomes in patients undergoing partial nephrectomy for kidney tumors. Its predictive value was demonstrated in an independent external cohort - meaning patients not involved in the original development of the scoring system - which significantly strengthens confidence in its real-world applicability.
The key finding is that a higher DAP score independently predicts both longer ischemia time and greater kidney function loss after surgery. These are the two most clinically significant intraoperative and postoperative concerns in kidney-sparing surgery, making the DAP score directly relevant to surgical planning and patient counseling.
The study also provides important nuances about how the individual components of the DAP score behave. Diameter and axial position are more predictive than polar position across most outcome measures, suggesting that future refinements of the scoring system might weight these components differently.
The authors note that prospective studies would be valuable to further validate these findings, particularly as surgical techniques continue to evolve with newer robotic platforms and off-clamp surgical approaches. Nevertheless, the evidence presented here supports routine use of DAP nephrometry in preoperative assessment of kidney cancer surgery candidates.